For those looking to find strong Medical stocks, it is prudent to search for companies in the group that are outperforming their peers. Acasti Pharma (ACST) is a stock that can certainly grab the ...

Today, Oppenheimer initiated coverage on ACST stock with an “outperform” rating and a price target of $6. Even after today’s significant price increase, the price target still represents upside of ...

Pharmaceutical company Acasti Pharma (NASDAQ:ACST) has a particular focus on developing drugs to help manage cardio-metabolic disorders. Traders might be interested in ACST stock if they like cheap ...

Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Is Acasti Pharma (ACST) one of those stocks right now? Let's take a closer look at ...

Acasti Pharma (NASDAQ:ACST) just reported results for the first quarter of 2025. Acasti Pharma reported earnings per share of -24 cents. This was above the analyst estimate for EPS of -25 cents. The ...